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ABSTRAK
Kami melaporkan sebuah kasus seorang laki-laki, 72 tahun, etnis Tionghoa dengan keluhan utama buang 
air besar berwarna hitam lembek. Pemeriksaan fisik menunjukkan warna pucat pada konjungtiva palpebra 
yang dikonfirmasi dengan hasil hitung darah lengkap. Pemeriksaan gastroduodenoskopi menemukan adanya 
ulkus berukuran 3 mm di antrum (Forrest stage III). Infeksi H. pylori dinyatakan positif berdasarkan lima 
metode berbeda (urinary antibody tests, rapid urease test, kultur, histologi dan imunohistokimia). Analisis 
dengan sequencing berbasis polymerase chain reaction didapatkan bahwa pasien terinfeksi oleh strain 
berjenis East-Asian-type cagA dan vacA s1m1. Analisis lanjutan dengan menggunakan tujuh housekeeping 
gen mengkonfirmasikan bahwa strain tersebut tergolong dalam kelompok hspEAsia. Pasien diberikan infus 
intravena kontinyu pompa proton inhibitor dan standar triple therapy regimens untuk terapi eradikasi H. pylori.
Kata kunci: Helicobacter pylori, ulkus peptikum, East-Asian-type cagA, vacA.
ABSTRACT
We reported a male, 72 yo, Chinese ethnic with chief complaint black mushy defecation. Physical examination 
revealed pale on conjunctival palpebra which confirmed as anemia on complete blood count. Gastroduodenoscopy 
revealed a 3 mm ulcer at the antrum (Forrest stage III). H. pylori infection was positive based on five different 
test methods (urinary antibody tests, rapid urease test, culture, histology ad immunohistochemistry). Used 
polymerase chain reaction-based sequencing, we found the patient infected by CagA producing, East-Asian-type 
cagA and vacA s1m1-strain. Further analysis using 7 housekeeping genes confirmed that the strain categorized 
in to hspEAsia group. The patient was given continuous intravenous infusions of proton pump inhibitor and 
standard triple therapy regimens eradication of H. pylori.
Keywords: Helicobacter pylori, gastric ulcer, East-Asian-type cagA, vacA.
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INTRODUCTION
Gastric ulcer (GU), part of peptic ulcer 
disease (PUD), is a deep lesion penetrating 
through the entire thickness of the gastro 
intestinal mucosa and muscularis mucosa with 
a diameter of at least 0.5 cm.1 Helicobacter 
pylori infection plays an important role in the 
pathogenesis of GU, causes more than 90% 
of cases when non steroidal anti-inflammatory 
agents (NSAID) are excluded.2 Several studies 
reported that cagA and vacA, the best studied 
being virulence factors of H. pylori, are a risk 
factor of GU.3,4 Nomura et al.3 reported that 
subjects with seropositivity for both H. pylori and 
CagA had an odds ratio of 4.4 (95% CI: 1.8, 10.5) 
for GU. In addition, in vitro study reported that 
cagA with an EPIYA-D segment (East-Asian-
type cagA) has a higher binding affinity to Src 
homology-2 domain-containing phosphatase 2 
(SHP2) than cagA with an EPIYA-C (Western-
type cagA). Further, individuals infected with 
East-Asian-type cagA strains reportedly have an 
increased risk of PUD compared with those with 
Western-type cagA strains.5
On the other hand, the gene encoding vacA 
displays allelic diversity including the signal (s) 
regions s1 and s2 and middle (m) regions m1 
and m2. Based on in vitro experiments, s1m1 
strains have the highest cytotoxicity because they 
consistently induce cell vacuolation, followed 
by s1m2 strains (in which cell vacuolation is not 
consistently induced) and s2m2 strains, which 
have no cytotoxic activity due to a failure to 
induce cell vacuolation.6 In agreement with in 
vitro data, many studies examining populations in 
Western countries7-9 have shown that individuals 
infected with vacA s1 or m1 H. pylori strains 
have an increased risk of PUD compared with 
those with s2 or m2 strains.
In contrast with several Southeast Asian 
countries where have high prevalence of H. 
pylori infection; e.g., the H. pylori infection rate 
reported ranged from 54.1–76.1% in Thailand, 
most researchers reported low prevalence of H. 
pylori infection in Indonesia; 0–11.2% by the 
urea breath test and 5.7–12.8% by histology.10 
Interestingly the highest H. pylori prevalence 
on Surabaya, Indonesia was found in patients 
from the Chinese Indonesian population instead 
of patients from the Javanese population,10 
although the prevalence of H. pylori infection 
in Indonesians of Chinese descent was lower 
than that of Chinese non-immigrants.11 Moreover 
multilocus sequence typing (MLST) of seven 
housekeeping genes from different geographical, 
ethnic, and/or linguistic origins identified a high 
incidence of gastric cancer was found in regions 
prevailed by hp East-Asia strains (including 
China, Japan and Korea) than other population.12 
We reported a Chinese Indonesian patient was 
infected with An East-Asian-type cagA H. pylori 
with clinical manifestation GU.
CASE ILLUSTRATION
A 72 years old male, Chinese Indonesian 
ethnic (father, mother and grandparents are 
Chinese ethnic), was admitted to the hospital 
for having black mushy defecation since 3 days 
ago. He also had abdominal discomfort since 
5 months ago, aggravated by meals without 
radiating pain and temporary relief by antacids. 
Physical examinations revealed the 
conjunctival palpebra were pale and no sign of 
jaundice. There was no lymph nodes enlargement. 
The thorax and abdominal examination was 
normal. The extremities were a few pale.
Complete blood count revealed hemoglobin 
8 g/dl, hematocrit 23%, leukocytes 7300/uL, 
granulocytes 75%, platelets 378.000/uL. The 
biochemical analysis were SGOT 11/uL, SGPT 
8/uL, albumin 3.86 g/dl, total bilirubin 0.52 mg/
dl, direct bilirubin 0.16 mg/dl, BUN 17 mg/dl, 
creatinine 0.98 mg/dl, random blood glucose 105 
mg/dl, sodium 137 mEq/L, potassium 3.7 mEq/L, 
chloride 107 mEq/L and HbsAg negative. H. 
pylori urinary antibody test result was positive.
Chest X-ray showed the heart and lungs were 
normal. Abdominal ultrasonography showed the 
liver size within normal limit and there was no 
splenomegaly. Gastroduodenoscopy revealed a 
3 mm ulcer at the antrum which categorized on 
Forrest stage III (Figure 1). Biopsy was taken 
three from antrum used for H. pylori culture, 
rapid urease test (CLO-test), and histological 
examination of specimens and one from the 
corpus for histological examination. The result 
was positive for CLO-test. Histology examination 
confirmed by immunohistochemistry showed 
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H. pylori positive with density 1 both in the 
antrum and corpus. Based on the updated 
Sydney system; the degree of neutrophil activity, 
inflammation, atrophy and intestinal metaplasia 
were 1, 2, 1, 0, respectively for antrum and 1, 
1, 0, 0, respectively for body. According to the 
operative link on gastritis assessment (OLGA) 
system, the degree of gastritis scores was stage 1. 
The H. pylori bacteria culture were growth, 
we termed as the SBYPUD-1 strain. The 
polymerase chain reaction (PCR) amplification 
of cagA conserved region was CagA producer, 
whereas vacA genotype was s1m1. The lists of 
primers are shown in Table 1. Direct sequencing 
of a conserved region of CagA identified 
EPIYA-A, -B and -D segments, therefore 
categorized in to East-Asian-type cagA (Figure 
2). The sequences of seven housekeeping genes 
confirmed this strain categorized in to hspEAsia 
group (Figure 3).
The patient was given soft and low fiber diet, 
80 mg intravenous bolus Pantoprazole followed 
by infusion 8 mg/h. He was also given H. pylori 
Gastric ulcert
Gastric ulcert
Figure 1. Antral gastric ulcer (Forrest III) was confirmed by 
gastroduodenoscopy examination which maybe a cause of 
melena.
Table 1. The primers used for detecting virulence factors of H. pylori
Genes Name of Primer Primer sequences (5’→3’) PCR product (bp) PCR conditions
cagA cagOMF AGCAAAAAGCGACCTTGAAA
521 95°C, 1 min; 56°C, 1 min; 72°C, 1 
min (35 cycles)cagOMR AGTGGCTCAAGCTCGTGAAT
vacA
94°C, 1 min; 52°C, 1 min; 72°C, 1 
min (35 cycles)
s1/s2 VAI-F ATGGAAATACAACAAACACAC 259/268
VAI-R CTGCTTGAATGCGCCAAAC




94°C, 1 min; 56°C, 1 min; 72°C, 1 
min (35 cycles)atpA-R CTTGAAACCGACAAGCCCAC
efp efp-F GGCAATTTGGATGAGCGAGCTC
642
94°C, 1 min; 56°C, 1 min; 72°C, 1 
min (35 cycles)efp-R CTTCACCTTTTCAAGATACTC
mutY mutY-F GTGGTTGTAGYTGGAAACTTTACAC
639
94°C, 1 min; 56°C, 1 min; 72°C, 1 
min (35 cycles)mutY-R CTTAAGCGTGTGTYTTTCTAGG
ppa ppa-F GGAGATTGCAATGAATTTAGA
676
94°C, 1 min; 53°C, 1 min; 72°C, 1 
min (35 cycles)ppa-R GTGGGGTTAARATCGTTAAATTG
trpC trpC-F TAGAATGCAAAAAAGCATCGCCCTC
950 94°C, 1 min; 58°C, 1 min; 72°C, 1 
min (35 cycles)trpC-R TAAGCCCGCACACTTTATTTTCGCC
ureI ureI-F AGGTTATTCGTAAGGTGCG
875
94°C, 1 min; 53°C, 1 min; 72°C, 1 
min (35 cycles)ureI-R GTTTAAATCCCTTAGATTGCC
yphC yphC-F CACGCCTATTTTTTTGACTAAAAAC
950 94°C, 1 min; 55°C, 1 min; 72°C, 1 
min (35 cycles)yphC-R CATTYACCCTCCCAATGATGC
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eradication therapy consisted of Pantoprazole 
2x20 mg, Clarithromycin 2x500 mg, Amoxicillin 
and 2x1 g for 7 days. The black mushy defecation 
was stop on 3rd day of admission.
DISCUSSION
Although H. pylori was discovered more 
than 30 years ago by Warren and Marshall.13, 
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EPIYA-D
Figure 2. Sequence analysis of CagA structural polymorphisms of SBYPUD-1 strain. Sequences of A, B and D segments 



















Figure 3. Phylogenetic tree of SBYPUD-1 based on the 
seven housekeeping genes of H. pylori. Sequence data 
sets of the seven housekeeping genes of 1,126 strains 
with different genotypes were obtained from the pubMLST 
database (62 from hpAsia2, 493 from hpEurope, 76 from 
hpNEAfrica, 50 from hpSahul, 28 from hpAfrica2, 279 from 
hpEastAsia, and 138 from hpAfrica1) then compared to 
SBYPUD-1. Neighbor-joining trees were constructed in 
MEGA v.5.05 using Kimura-2 parameters. The scale bar 
indicates genetic distance.
which method should be considered as a gold 
standard for detection of H. pylori infection 
remains unclear. Culture from biopsy specimens 
has the potential of leading to a high sensitivity, 
given that only one bacterium can multiply and 
provide billions of bacteria. However, both strict 
transport conditions and careful handling in 
the laboratory are necessary. On the other hand 
rapid urease test, such as the CLO test, can be 
useful as a rapid diagnostic method. However, 
these results can also be affected by the bacterial 
load.14 Histological diagnosis depends on the 
density of H. pylori biopsy sites; thus, these tests 
can occasionally show false negative results and 
very much dependent on the expertise of the 
pathologists. Immunohistochemistry staining 
could increase histology accuracy due to using a 
specific H. pylori antibody which has the highest 
sensitivity and specificity and better interobserver 
agreement compared to histochemical stains.15 
Therefore the combination of two or more tests 
should be applied to determine the accurate 
prevalence of infection.
Although H. pylori infection is a major factor 
to severe gastroduodenal disease, the infection 
remains latent in the majority of infected 
patients, and only a minority of individuals with 
H. pylori infection ever develop the disease.16 
The difference of H. pylori infection rate is 
not enough to explain the difference of the 
incidence of gastric cancer around the world. In 
addition to host and environmental factors, as a 
part, the difference of the incidence of gastric 
cancer irrespective of H. pylori infection rate 
can be explained by the difference of virulence 
factors.17 In general, strains with cagA positive 
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(especially East-Asian-type cagA) and vacA 
s1m1 are considered to be more virulent and 
induced higher inflammation and/or atrophy 
than cagA-negative, Western-type cagA, and/or 
other vacA types. In fact, the investigators from 
the early and mid-twentieth century in Malaysia 
and Java, Indonesia reported that gastric cancer 
and PUD typically associated with H. pylori, 
were rare in the indigenous populations but 
were common among the more recently arrived 
Chinese and Indian immigrants.18 It is suggested 
that the Chinese Indonesian might be become 
a high-risk population of H. pylori associated 
disease even in Indonesia.
MLST characterized isolates of bacterial 
and fungal species using nucleotide sequences 
of internal fragments of housekeeping genes. 
This method is finding a place in clinical 
microbiology and public health by providing 
data for epidemiological surveillance19 and also 
reported to give more detailed information about 
human population structure than the method 
using human microsatellite or mitochondrial 
DNA.20 Recently, the genomic diversity within H. 
pylori populations was examined by employing 
the MLST method using 7 housekeeping genes 
(atpA, efp, mutY, ppa, trpC, ureI, and yphC).21-
23 At present, H. pylori strains can be divided 
into seven population types on the basis of 
geographical associations and designated as 
follows: hpEurope, hpEastAsia, hpAfrica,1 
hpAfrica2, hpAsia2, hpNEAfrica, and hpSahul.23 
hpEurope includes almost all H. pylori strains 
isolated from ethnic Europeans, including 
people from countries colonized by Europeans. 
hpEastAsia is common in H. pylori isolates 
from East Asia also includes subpopulations, i.e. 
hspMaori (Polynesians, Melanesians, and native 
Taiwanese), hspAmerind (Amerindians), and 
hspEAsia (East Asians). hpAsia2 strains have 
been isolated in South, Southeast, and Central 
Asia. hpAfrica1 includes 2 subpopulations, 
hspWAfrica and hspSAfrica; hpAfrica2 is 
very distinct and has only been isolated in 
South Africa. hpNEAfrica is predominant in 
isolates from Northeast Africa. hpSahul strains 
are isolated from aborigines of Australia and 
highlanders in New Guinea.24 This case report 
patient was categorized as hspEAsia, which 
suggested that his descents were likely from East 
Asian region. It is also confirmed the previous 
study that the hspEAsia group mostly contained 
East-Asian-type cagA and vacA s1m1.17
Most patients with PUD present with 
abdominal discomfort, pain or nausea. The 
pain is located in the epigastrium and usually 
does not radiate. However, these symptoms 
are neither sensitive nor specific. Classically, 
GU pain is aggravated by meals, whereas the 
pain of duodenal ulcers is relieved by meals. 
Hence, patients with GUs tend to avoid food 
and present with weight loss, while those with 
duodenal ulcers do not lose weight.25 Although 
it is still controversy about the ability of H. 
pylori infection as the initial or primary cause 
of the GU, there is no doubt of the value of H. 
pylori eradication leading to long-term healing 
of GU. Eradication of this bacterium improves 
GU recovery and is a primary and secondary 
prophylaxis to reduce the risk of recurrent ulcer 
bleeding. A meta-analysis suggested a remission 
rate of 97% of GU after successfully eradicating 
infection compared to 61% in patients with 
persistent infection. In addition, treatment of 
H. pylori infection is superior to ulcer healing 
drugs and reduces recurrent bleeding by 17% 
compared with ranitidine or omeprazole. The 
use of IV PPI is perhaps best established in the 
treatment of complicated PUD, and has largely 
replaced the use of H2RA. A meta-analysis 
of 24 randomized controlled trials with 4373 
patients, comparing IV or oral PPI with placebo 
or H2RA in bleeding PUD, reported that PPI 
treatment in PUD bleeding reduces rebleeding 
and surgery compared with placebo or H2RA. 
Several studies have looked at the efficacy of 
PPIs, given in a combination of oral, IV bolus 
(defined as administration with an IV push at 
regular intervals) and high dose IV continuous 
infusion forms (usually preceded by an 80 mg 
bolus IV push, followed by an infusion at 8 
mg/h), in achieving and maintaining this pH 
target goal of >6.26
According to current guidelines, standard 
triple therapy containing a PPI and two antibiotics, 
amoxicillin and clarithromycin or metronidazole, 
is still the first-line regimen for treatment of H. 
pylori infection.27-30 However, in recent years, 
312
Yudith AA. Rezkitha                                                                                                                           Acta Med Indones-Indones J Intern Med
the efficacy of legacy triple regimens has been 
seriously challenged and eradication rates lower 
than 70% are now reported in many countries.31 
Unfortunately Indonesia only has old local 
antimicrobial resistance data, around 10 years 
ago and collected from 1 city which cannot 
be generalized across Indonesia.32 First-line 
treatment should be recommended on the basis 
of an understanding of the local prevalence 
of H. pylori antimicrobial resistance.33,34 The 
local antibiotic resistance surveillance update, 
selection of appropriate first-line regimen and 
detail evaluation of patient prior antibiotic usage 
are essensial to combat H. pylori antibiotic 
resistance in Indonesia.
CONCLUSION
In addition to the positivity of H. pylori 
infection, the severity of gastroduodenal disease 
outcome could be explained by the difference of 
H. pylori virulence factors.
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